Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
16M
-
Shares change
-
-1.12M
-
Total reported value, excl. options
-
$97.9M
-
Value change
-
-$7.16M
-
Number of buys
-
9
-
Number of sells
-
-35
-
Price
-
$6.11
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q2 2021
50 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q2 2021.
scPharmaceuticals Inc. - Common Stock (SCPH) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16M shares
of 53.4M outstanding shares and own 30.03% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4.8M shares), 5AM Venture Management, LLC (3.83M shares), RA CAPITAL MANAGEMENT, L.P. (2.73M shares), Ikarian Capital, LLC (1.1M shares), J. Goldman & Co LP (721K shares), AIGH Capital Management LLC (642K shares), VANGUARD GROUP INC (609K shares), RENAISSANCE TECHNOLOGIES LLC (216K shares), Russell Investments Group, Ltd. (194K shares), and Worth Venture Partners, LLC (164K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.